Investing.com - Merck Kgaa reported on Friday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Merck Kgaa announced earnings per share of €2.64 on revenue of €5.57B. Analysts polled by Investing.com EPS of €2.51 on revenue of €5.42B.
Merck Kgaa 's are down 23.75% and is trading at €174.85 , still down 24.41% from its 52 week high of €231.30 set on Thursday, December 30, 2021.
Merck Kgaa follows other major Healthcare sector earnings this month
Merck Kgaa's report follows an earnings beat by Merck on Friday, who reported EPS of €2.64 on revenue of €5.57B, EPS of €2.51 on revenue of €5.42B.
Carl Zeiss AG had matched expectations on Friday with fourth quarter EPS of €0.7 on revenue of €477.4M, for EPS of €0.7 on revenue of €477.42M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar